AB-161
AB-161 is an orally active HBV RNA destabilizer and a PAPD5/7 inhibitor, with its primary action focused in the liver. AB-161 treats Hepatitis B Virus (HBV) infection by lowering the levels of Hepatitis B surface antigen (HBsAg), with an EC50 value of 2.2 nM for HBsAg. AB-161 can be used in the field of HBV infection research[1].
Product Specifications
CAS Number
2848560-66-5
UNSPSC
12352005
Target
HBV
Type
Reference compound
Related Pathways
Anti-infection
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/ab-161.html
Smiles
O=C(O)C1=CC2=C(C3=C(C[C@H]2C(C)(C)C)N4C(C(OC(F)F)=CC(OC)=C4)=N3)NC1=O
Molecular Formula
C21H21F2N3O5
Molecular Weight
433.41
References & Citations
[1]Gotchev D, et al. Structure-Activity Relationships and Discovery of (S) -5- (tert-Butyl) -11- (difluoromethoxy) -9-methoxy-2-oxo-1,2,5,6-tetrahydropyrido[2',1':2,3]imidazo[4,5-h]quinoline-3-carboxylic Acid (AB-161), a Novel Orally Available and Liver-Centric HBV RNA Destabilizer. J Med Chem. 2024 Nov 28;67 (22) :20467-20494.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
30-1831-0.1 0.1 mg
Anti-Cytokeratin 19 Monoclonal Antibody (Clone:A53-B/A2) -Biotin Conjugated
Sign In for Pricing
View Details RC208013L3 10 µg
p63 (TP63) (NM_003722) Human Tagged Lenti ORF Clone
Sign In for Pricing
View Details 
